Atrial Cardiomyopathy in Patients with Cardiovascular-Kidney-Metabolic Syndrome: Non-Invasive Characterization (ATRIO-CKM).
6 affiliations
- 1Grigore T. Popa University of Medicine and Pharmacy Iași, 700115 Iași, Romania.
- 2Internal Medicine Clinic, "Sf. Spiridon" County Clinical Emergency Hospital, 700111 Iași, Romania.
- 3Clinical Hospital of Pneumology, 700115 Iași, Romania.
- 4Nephrology Clinic, "Dr. C.I. Parhon" Clinical Hospital, 700503 Iași, Romania.
- 5Institute of Gastroenterology and Hepatology, "Sf. Spiridon" County Clinical Emergency Hospital, 700111 Iași, Romania.
- 6Laboratory of Immunology, Department of Immunology, "Sf. Spiridon" County Clinical Emergency Hospital, 700111 Iași, Romania.
Abstract
Background/Objectives: In cardiovascular-kidney-metabolic (CKM) syndrome, left atrium (LA) involvement begins early: reservoir function declines before the chamber dilates, and the resulting atrial cardiomyopathy (ACM) precedes atrial fibrillation (AF), heart failure with preserved ejection fraction (HFpEF), and cardioembolic stroke. How ACM is distributed across CKM stages has not yet been characterized in routine clinical practice. ATRIO-CKM aims to characterize ACM non-invasively across the range of CKM stages in patients assessed in an internal medicine and cardiology department and to identify the parameters most strongly associated with ACM within CKM syndrome. Methods: Single-center, prospective, observational study with cross-sectional phenotyping at the index visit. We will enroll consecutive adults at their first assessment in our department (target, 200; minimum, 150). The primary objective is to estimate the stage-specific prevalence of ACM among participants in sinus rhythm without documented AF, who form the main cohort and are grouped as CKM with versus without ACM. Patients in sinus rhythm are phenotyped with 12-lead electrocardiogram (P-wave duration, Bayés interatrial block), echocardiography with speckle-tracking of the left ventricle (LV), LA (biplane reservoir, conduit, and contractile strain), and right ventricular (RV) free wall, and biomarkers including MR-proANP, Fetuin-A, FGF-23, and NT-proBNP, with cardiac magnetic resonance in an exploratory subset. Participants with AF documented at any time, including previously documented paroxysmal AF, are allocated to a separate established-AF cohort irrespective of the rhythm at the index visit. Results: We will report ACM prevalence by CKM stage with confidence intervals, the profile separating the two groups, LA volume index across three groups of increasing severity (no ACM, ACM in sinus rhythm, and established AF), and the parameters associated with ACM. Conclusions: Using only measurements already available in routine cardiology, ATRIO-CKM will describe how ACM is distributed across CKM stages and identify the parameters most strongly associated with ACM within CKM syndrome, as candidates for a classification index to be developed and validated in a larger cohort.
Related
- Machine learning based predictive model for cardiovascular disease mortality risk in patients with stage 4 cardiovascular–kidney–metabolic syndrome
- Joint and Independent Associations of Dietary Antioxidant Intakes With Advanced Stages in Older Patients With Cardiovascular‐Kidney‐Metabolic Syndrome
- Metabolic score for visceral fat as a predictor of new-onset cardiovascular disease in patients with metabolic syndrome: a validation study in two prospective cohorts (UK Biobank and CHARLS).
- Depression, functional disability, and cardiovascular disease in adults with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationally representative cohort study
- Association of sleep time with all-cause and cardiovascular mortality among individuals with advanced cardiovascular-kidney-metabolic syndrome : A NHANES-based prospective cohort study
BibTeX
@article{godun2026atrial,
title = {{Atrial Cardiomyopathy in Patients with Cardiovascular-Kidney-Metabolic Syndrome: Non-Invasive Characterization (ATRIO-CKM).}},
author = {Maria-Mihaela Godun and Marius-Traian-Dragoș Marcu and Paula Cristina Morariu and Alexandru-Florinel Oancea and Mugurel-Costel Apetrii and Anca-Elena Ștefan and Diana-Elena Floria and Laura Huiban and Bogdan Todiraș and Mariana Pavel-Tănasă and Anca Trifan and Adrian Covic and Mariana Floria},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/diagnostics16193196},
url = {https://europepmc.org/article/MED/42882351},
note = {CC BY},
}
RIS
TY - JOUR
TI - Atrial Cardiomyopathy in Patients with Cardiovascular-Kidney-Metabolic Syndrome: Non-Invasive Characterization (ATRIO-CKM).
AU - Maria-Mihaela Godun
AU - Marius-Traian-Dragoș Marcu
AU - Paula Cristina Morariu
AU - Alexandru-Florinel Oancea
AU - Mugurel-Costel Apetrii
AU - Anca-Elena Ștefan
AU - Diana-Elena Floria
AU - Laura Huiban
AU - Bogdan Todiraș
AU - Mariana Pavel-Tănasă
AU - Anca Trifan
AU - Adrian Covic
AU - Mariana Floria
PY - 2026
DA - 2026/10/01
JO - Diagnostics (Basel, Switzerland)
DO - 10.3390/diagnostics16193196
UR - https://europepmc.org/article/MED/42882351
AB - Background/Objectives: In cardiovascular-kidney-metabolic (CKM) syndrome, left atrium (LA) involvement begins early: reservoir function declines before the chamber dilates, and the resulting atrial cardiomyopathy (ACM) precedes atrial fibrillation (AF), heart failure with preserved ejection fraction (HFpEF), and cardioembolic stroke. How ACM is distributed across CKM stages has not yet been characterized in routine clinical practice. ATRIO-CKM aims to characterize ACM non-invasively across the range of CKM stages in patients assessed in an internal medicine and cardiology department and to identify the parameters most strongly associated with ACM within CKM syndrome. Methods: Single-center, prospective, observational study with cross-sectional phenotyping at the index visit. We will enroll consecutive adults at their first assessment in our department (target, 200; minimum, 150). The primary objective is to estimate the stage-specific prevalence of ACM among participants in sinus rhythm without documented AF, who form the main cohort and are grouped as CKM with versus without ACM. Patients in sinus rhythm are phenotyped with 12-lead electrocardiogram (P-wave duration, Bayés interatrial block), echocardiography with speckle-tracking of the left ventricle (LV), LA (biplane reservoir, conduit, and contractile strain), and right ventricular (RV) free wall, and biomarkers including MR-proANP, Fetuin-A, FGF-23, and NT-proBNP, with cardiac magnetic resonance in an exploratory subset. Participants with AF documented at any time, including previously documented paroxysmal AF, are allocated to a separate established-AF cohort irrespective of the rhythm at the index visit. Results: We will report ACM prevalence by CKM stage with confidence intervals, the profile separating the two groups, LA volume index across three groups of increasing severity (no ACM, ACM in sinus rhythm, and established AF), and the parameters associated with ACM. Conclusions: Using only measurements already available in routine cardiology, ATRIO-CKM will describe how ACM is distributed across CKM stages and identify the parameters most strongly associated with ACM within CKM syndrome, as candidates for a classification index to be developed and validated in a larger cohort.
SN - 2075-4418
ER -